Please provide your email address to receive an email when new articles are posted on . The estimated added effect of provocation was not significant for either condition. The findings have ...
This life-changing Health Canada-approved technology directly targets the brain circuits involved in OCD—without the side effects of medication. Patients tell us they feel like they’re finally getting ...
BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BRSYF) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
You’ve heard how Dr. Sonni Elliott of Sunrise Psychiatry treats resistant depression with TMS Therapy. Now Dr. Elliott is offering the treatment for those with obsessive compulsive behaviors. OVERLAND ...
Detailed price information for Brainsway Ltd ADR (BWAY-Q) from The Globe and Mail including charting and trades.
The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major depressive ...
Expert behavioral medicine specialists and neurologists at the WVU Rockefeller Neuroscience Institute (RNI) offer an alternative and complementary treatment option for adult patients who have major ...
With this expanded portfolio, our users can now choose the most appropriate coil for each specific patient, prioritizing comfort, treatment precision, and outcomes.” — Kerry Rome, SVP MagVenture, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results